Search
Candesartan
go.drugbank.com/drugs/DB13919InvestigationalCandesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is available as a prodrug in the form of candesartan cilexetil.
Mixtures: CARAMLO 16MG/10MG, CARAMLO 16MG/10MGProducts: BLOPRESS 4MG, CANDESARTAN AAA 4MGAdenosine
go.drugbank.com/drugs/DB00640ApprovedInvestigational[A229828] Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy,[L31983] though it is rarely used in this indication, having largely been replaced by [dipyridamole]
Mixtures: Lebody Bu W Renewal Up, MIRACLETOX Time Rewind Advanced Lifting Ampoule 40mLProducts: ADOZIN 50MG/10ML IV ENJEKSIYON VE INFÜZYON IÇIN ÇÖZELTI IÇEREN FLAKON, 10 FLAKON, ADOZIN 10MG/2ML IV ENJEKSIYON VE INFÜZYON IÇIN ÇÖZELTI IÇEREN AMPUL, 10 AMPULMethotrexate
go.drugbank.com/drugs/DB00563ApprovedInvestigational[A180322] Because of these effects, methotrexate is often used to treat inflammation caused by arthritis or to control cell division in neoplastic diseases such as breast cancer and non-Hodgkin's lymphoma
Products: TREXJECT 10MG (10MG/ML), METEX FS 10MG (50MG/ML)Bevacizumab
go.drugbank.com/drugs/DB00112ApprovedInvestigational[A193272,A193275,L12648] Avastin was subsequently approved by Health Canada on March 24, 2010 and by the European Commission on April 21, 2021. … [A192834,A192888,A192837,A192891,A192894] Bevacizumab is a humanized monoclonal IgG antibody that inhibits angiogenesis by binding and neutralizing VEGF-A.
Products: Avastin Concentrate for Solution for Infusion 400mg/16ml, ALTUZAN 400MG/16ML KONSANTRE INFÜZYON COZELTİSİ, 1 ADETUstekinumab
go.drugbank.com/drugs/DB05679ApprovedInvestigationalIn October 2019, it was also approved by the FDA for use to manage moderately to severely active ulcerative colitis in adults.
Products: Solution for Injection 90mg/1ml, STELARA 90MG/1ML SOLUTION FOR INJECTION IN PREFILLED SYRINGESiltuximab
go.drugbank.com/drugs/DB09036ApprovedInvestigationalSiltuximab is a chimeric (human-mouse) monoclonal immunoglobulin G1-kappa antibody produced in a Chinese hamster ovary (CHO) cell line by recombinant DNA technology. … Siltuximab prevents the binding of IL-6 to soluble and membrane-bound IL-6 receptors by forming high affinity complexes with human interleukin-6 (IL-6).
Products: Sylvant 400mg Powder for Concentrate for Solution for Infusion, Sylvant 100mg Powder for Concentrate for Solution for InfusionNaloxone
go.drugbank.com/drugs/DB01183ApprovedInvestigationalVet approvedAlso known as the brand name product Narcan, naloxone is currently available by intramuscular (IM) or subcutaneous (SubQ) injection, nasal spray, or intravenous (IV) infusion. … [L33729,L33739] Naloxone IM injections are commonly available in the form of "kits", which is ideal for making overdose treatment accessible and readily available for administration by minimally trained
Mixtures: TARGIN 60MG/30MG, TARGIN 60MG/30MGProducts: Narcan Injection 1mg/ml, Naloxone HCl Injection - 1mg/ml USPCyclosporine
go.drugbank.com/drugs/DB00091ApprovedInvestigationalVet approved[A174049] Initially manufactured by Sandoz and approved for use by the FDA in 1983, cyclosporine is now available in various products by Novartis (previously known as Sandoz).[L11097,L3734,L11118]
Products: SANDIMMUN NEORAL 10MG, SANDIMMUN OPTORAL 10MGZofenopril
go.drugbank.com/drugs/DB13166ApprovedInvestigationalZofenopril is employed as both a cardioprotective and anti-hypertensive agent. It is an angiotensin-converting enzyme (ACE) inhibitor.
Mixtures: ZOFENIL PLUS 30MG/12.5MGProducts: ZOFENIL 30MG, ZOFENIL 60MGRuxolitinib
go.drugbank.com/drugs/DB08877ApprovedInvestigational[A229938] Ruxolitinib was first approved for the treatment of adult patients with myelofibrosis by the FDA in 2011, followed by EMA's approval in 2012. … By inhibiting JAK1 and JAK2, ruxolitinib works to block the dysregulated cell signalling pathways and prevents abnormal blood cell proliferation.
Products: Jakavi 10mg Tablets, JAKAVI TABLET 10MG